Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients
NCT06890572 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2025-03-24
Summary
This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic rhinitis who continue to require medication such as antihistamines and nasal spray steroids for allergic rhinitis are the subjects of this study.
Patients who participate in the study will install air purifiers for a certain period of time and observe the objective and subjective improvement of rhinitis symptoms. The study is conducted on two separate occasions for four weeks, and there is a two-week period between the two periods of no use of air purifiers. There are two types of air purifiers:
1)It is an air purifier with a HEPA filter and a VOC filter, and 2) a fake air purifier without air cleaning function.
Subjects are divided into Group A and Group B. Group A will receive a fake air purifier, and Group B will be assigned an air purifier with a HEPA + VOC collecting filter. After using the assigned air purifier for the first four weeks, you will have a period of not using it for two weeks, and then replace the air purifiers with each other and use it again for four weeks. When you first assign an air purifier, you will receive an air purifier with a certain filter It is randomly assigned without knowing whether both the researcher and the patient will receive a regular period.
During the study period, patients need to visit three times, including when registering for the study, and the study period is screened It will take about 5 months from the end of the air purifier operation
Conditions
- Rhinitis Allergic
Interventions
- DEVICE
-
HEPA + VOC collecting filter purifier
Subjects operate HEPA + VOC collecting filter purifier
- DEVICE
-
fake air purifier
Subjects operate fake air purifiers
Sponsors & Collaborators
-
LG Electronics Inc.
collaborator INDUSTRY -
Yonsei University
lead OTHER
Principal Investigators
-
Kyung Hee Park · Yonsei University Health System, Severance Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-11
- Primary Completion
- 2025-05-23
- Completion
- 2025-06-20
Countries
- South Korea
Study Locations
More Related Trials
-
Molekule for Allergic Rhinitis/Asthma
NCT03627689 ·Status: TERMINATED ·Phase: NA
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574704 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176 ·Status: RECRUITING
-
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03655210 ·Status: COMPLETED ·Phase: PHASE3
-
Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis
NCT02665754 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of Perennial Allergic Rhinitis
NCT00358475 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber
NCT00784732 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine
NCT01103050 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis
NCT03009136 ·Status: UNKNOWN ·Phase: PHASE3
-
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
NCT01275456 ·Status: COMPLETED ·Phase: NA
-
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
NCT00363740 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
NCT04874714 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers
NCT05122143 ·Status: COMPLETED ·Phase: NA
-
An Investigator-initiated, Explorative Trial Evaluating the Effect of SAT-008 in Healthy Adults
NCT04916145 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
NCT01640535 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574223 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis
NCT00688441 ·Status: COMPLETED ·Phase: PHASE2
-
Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis
NCT05708157 ·Status: UNKNOWN
-
Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult
NCT06046391 ·Status: COMPLETED ·Phase: PHASE2
-
Dupilumab Effects Against Aeroallergen Challenge
NCT05720325 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
NCT00968149 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
NCT04654702 ·Status: COMPLETED
-
Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic Rhinitis
NCT07157462 ·Status: RECRUITING ·Phase: NA